Keith Bouchard

Title: Keith Bouchard: Innovator in Alkaline Phosphatase Research

Introduction

Keith Bouchard is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of polypeptides that have therapeutic applications. His work focuses on addressing bone mineralization disorders, which can have profound effects on patients' health.

Latest Patents

Keith Bouchard holds a patent for "Alkaline phosphatase polypeptides and methods of use thereof." This patent features polypeptides that include soluble alkaline phosphatases, mutants, fragments, and fusion proteins. These innovations are aimed at treating bone mineralization disorders, such as hypophosphatasia (HPP), and alleviating associated symptoms. The polypeptides include a soluble alkaline phosphatase (sALP) or a fragment derived from a naturally occurring alkaline phosphatase (ALP). He has 1 patent to his name.

Career Highlights

Keith Bouchard is currently employed at Alexion Pharmaceuticals, Inc., where he continues to advance his research in the field of biochemistry. His work is instrumental in developing new treatments that can improve the quality of life for individuals suffering from bone mineralization disorders.

Collaborations

Throughout his career, Keith has collaborated with esteemed colleagues, including Walter C. Voegtli and Michael Baranello. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Keith Bouchard is a dedicated inventor whose work in alkaline phosphatase research is paving the way for new therapeutic options. His contributions to the field are significant and continue to impact the lives of many individuals facing health challenges.